Article
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
PloS one - 1 Jan 2016
Yoshida Takeshi, Song Lanxi, Bai Yun, Kinose Fumi, Li Jiannong, Ohaegbulam Kim C, Muñoz-Antonia Teresita, Qu Xiaotao, Eschrich Steven, Uramoto Hidetaka, Tanaka Fumihiro, Nasarre Patrick, Gemmill Robert M, Roche Joëlle, Drabkin Harry A, Haura Eric B
Abstract excerpt
Epithelial-mesenchymal transition (EMT) is one mechanism of acquired resistance to inhibitors of the epidermal growth factor receptor-tyrosine kinases (EGFR-TKIs) in non-small cell lung cancer (NSCLC). The precise mechanisms of EMT-related acquired resistance to EGFR-TKIs in NSCLC remain unclear. We generated erlotinib-resistant HCC4006 cells (HCC4006ER) by chronic exposure of EGFR-mutant HCC4006 cells to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
